Cleared Traditional

CryoVizion System (K183485) - FDA 510(k) Clearance

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2019
Decision
254d
Days
-
Risk

K183485 is an FDA 510(k) clearance for the CryoVizion System. Classified as Device, Sensing, Optical Contour (product code LDK).

Submitted by Cryos Technologies, Inc. (Joliette, CA). The FDA issued a Cleared decision on August 28, 2019 after a review of 254 days - an extended review cycle.

This device falls under the Physical Medicine FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.

View all Cryos Technologies, Inc. devices

Submission Details

510(k) Number K183485 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 17, 2018
Decision Date August 28, 2019
Days to Decision 254 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
139d slower than avg
Panel avg: 115d · This submission: 254d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code LDK Device, Sensing, Optical Contour
Device Class -

Regulatory Consultant

Lok North America, Inc.
Louis-Paul Martin

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.